Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Autoimmune Disease Diagnosis Market Forecast: What Market Value Is Expected By 2030?
In the realm of autoimmune disease diagnostics, a robust expansion has been observed recently, with the market projected to ascend from $6.2 billion in 2025 to $6.74 billion by 2026, reflecting a compound annual growth rate of 8.8%. This notable growth trajectory in the preceding period is largely attributable to several key factors, including the escalating incidence of autoimmune disorders, enhanced accessibility of immunoassay technologies, the broadening of clinical laboratory infrastructures, heightened physician understanding of these complex conditions, and a more widespread implementation of routine screening protocols.
The market for diagnosing autoimmune conditions is poised for substantial expansion in the upcoming years, projected to reach $9.38 billion by 2030 with a compound annual growth rate of 8.6%. This anticipated growth stems from several key drivers: a heightened need for prompt and precise diagnostic tools, the escalating application of artificial intelligence in diagnostic analytics, the broader implementation of tailored diagnostic strategies, increased financial backing for autoimmune disease research, and the greater incorporation of point-of-care testing methodologies. Furthermore, significant trends expected to shape this period include a greater uptake of sophisticated immunological tests, a rise in the utilization of autoantibody test panels, enhanced integration of multi-analyte diagnostic platforms, advancements in laboratory automation, and a stronger emphasis on identifying diseases at their earliest stages.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3231&type=smp
Autoimmune Disease Diagnosis Market Growth Factors Supporting Long-Term Expansion
The rising prevalence of autoimmune disorders significantly propelled the expansion of the market focused on diagnosing these conditions, which are characterized by the immune system erroneously targeting the body’s own healthy components. This upward trend in autoimmune conditions is attributed to heightened exposure to environmental factors like pollution and infections, coupled with lifestyle adjustments that can interfere with immune system regulation. The accurate identification of specific immune disorders through diagnostic methods is crucial for initiating effective treatments and managing disease progression. For example, data from the Society for Women’s Health Research in March 2023 indicated that autoimmune diseases affect an estimated 23.5 million to 50 million individuals in the U.S., with global incidence rates climbing by 3-9% annually, thereby fueling market growth for diagnostic tools.
Increased spending on healthcare is anticipated to be a major catalyst for the autoimmune disease diagnosis market. Healthcare expenditure, representing the aggregate financial investment in health products and services, serves as a vital indicator of public health status and healthcare system efficacy. Greater financial investment in healthcare facilitates more timely interventions, leading to improved detection, management, and outcomes for individuals suffering from autoimmune conditions. Illustrating this, the Office for National Statistics in the UK reported in May 2024 that overall healthcare expenditure experienced a substantial 5.6% nominal increase between 2022 and 2023, a marked acceleration from the 0.9% rise observed in 2022, underscoring the influence of escalating healthcare spending on the autoimmune disease diagnosis market.
Autoimmune Disease Diagnosis Market Segment Outlook: Which Categories Are Expanding The Fastest?
The autoimmune disease diagnosis market covered in this report is segmented –
1) By Product: Consumables And Assay Kits, Instruments
2) By Test Type: Routine Laboratory Tests, Autoantibodies Tests, Immunologic Tests, Other Tests
3) By End User: Clinical Laboratories, Hospitals, Other End Users
Subsegments:
1) By Consumables And Assay Kits: ELISA Kits, Reagents And Test Kits, Sample Collection And Preservation Devices, Control And Calibration Materials
2) By Instruments: Immunoassay Analyzers, Flow Cytometers, Luminometers, Microscopes
Autoimmune Disease Diagnosis Market Industry Trends Shaping Future Revenue Growth
Numerous corporations are actively participating in the autoimmune disease diagnostics sector, dedicating their efforts to pioneering technological innovations, specifically multiplex autoantibody assay platforms, which aim to facilitate thorough, prompt, and exact identification of autoimmune conditions, thereby enhancing diagnostic precision and refining patient care strategies. Such a multiplex autoantibody assay platform offers the capability to concurrently identify a variety of disease-specific autoantibodies within a single patient specimen, consequently boosting both sensitivity and specificity when contrasted with conventional single-analyte ELISA or immunofluorescence methodologies, all while necessitating less sample material and diminishing the time required for results. Illustratively, in January 2025, Exagen Inc., a diagnostic entity headquartered in the United States, introduced its AVISE CTD platform, incorporating novel biomarker assays for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). This platform is designed to detect emerging biomarkers including TIgG, TIgM, and TC4d, empowering healthcare providers to more accurately differentiate between various overlapping autoimmune conditions and expedite patient diagnosis, all while integrating effortlessly into established laboratory testing processes.
Autoimmune Disease Diagnosis Market Key Companies And Competitive Benchmarking
Major companies operating in the autoimmune disease diagnosis market are Siemens Healthineers AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, F. Hoffmann-La Roche Ltd, Danaher Corporation, AESKU Diagnostics GmbH & Co. KG, Trinity Biotech plc, bioMérieux SA, SQI Diagnostics, Philips Healthcare India, Agappe Diagnostics Ltd, Lepu Medical Technology Company (Beijing) Co., Ltd, Shanghai Runda Medical Technology Co., Ltd, GE Healthcare China Co., Ltd, Roche Holding AG, Koninklijke Philips, Theradiag, Becton Dickinson and Company, Ortho Clinical Diagnostics
Access The Complete Autoimmune Disease Diagnosis Market Report:
https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-global-market-report
Autoimmune Disease Diagnosis Market Regional Analysis And Leading Geography
North Americawas the largest region in the autoimmune disease diagnosis market in 2025. Western Europewas the second largest region in the autoimmune disease diagnosis market share. The regions covered in the autoimmune disease diagnosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
